The U.S. Food and Drug Administration (FDA) announced that its request for a total budget of $8.4 billion as part of the President’s fiscal year (FY) 2023 budget. This represents a nearly 34% ($2.1 billion) increase over the agency’s FY 2022 appropriated funding level. The FY23 request covers the period...
Washington, D.C.—Cara Welch, Ph.D., has been appointed Director of the FDA Office of Dietary Supplement Programs, a move which was applauded by the Consumer Healthcare Products Association (CHPA). “CHPA congratulates Dr. Welch on her permanent appointment as Director of ODSP,” said Duffy MacKay, CHPA’s SVP of Dietary Supplements. “This is...
Silver Spring, MD—FDA has decommissioned the “Poisonous Plant Database” after years of requests by the American Herbal Products Association (AHPA), according to an AHPA press release. The system was presented as an online source for scientific references describing toxic properties and effects attributed to plants or plant parts, although AHPA...
Washington, D.C.—The Natural Products Association (NPA) has filed a Citizen’s Petition with FDA regarding the legality of cannabidiol (CBD), according to a press release. The petition requests that FDA either: Determine that CBD is not excluded from the definition of a dietary supplement, allowing the Commissioner to exercise enforcement discretion...
Washington, D.C.—The Senate voted to confirm Dr. Robert Califf as the next FDA commissioner, the New York Times reports, despite opposition from some Democrats over his ties to the pharmaceutical industry. The vote was 50-46. Six Republicans voted for Dr. Califf, and five Democrats voted against. The Times stated that...
Salt Lake City, UT—The United Natural Products Alliance has submitted comments to the FDA Office of Dietary Supplement Programs (ODSP) regarding NAC, according to a press release. The comments were submitted in response to a Constituent Update titled FDA Requests Information Relevant to the Use of NAC as a Dietary...
Silver Spring, MD—Industry associations have submitted comments to FDA regarding the agency’s tentative responses to the citizen petitions from Council for Responsible Nutrition (CRN) and Natural Products Association (NPA) regarding the legal status of NAC. The American Health Products Association (AHPA) submitted comments, focusing on identifying NAC-containing products sold pre-DSHEA.
Virtual—Members of the natural products industry expressed frustration with FDA, calling interactions “disheartening.” At the 2022 NYSBA Annual Meeting, a panel discussion focused on intellectual property and FDA’s protection of it, or lack thereof. Mark Ullman, Of Counsel, Rivkin Radler, moderated the meeting, and opened with an anecdote regarding Mitsubishi...
Click here to listen. DSHEA protects our rights to access safe, effective nutritional supplements. Most people who take supplements do not know about DSHEA. Even within the supplement industry many people were not around in the early 1990s or don’t remember. In this interview with Asa Waldstein, we will...
With demand for immune support products soaring, FDA and FTC are on alert, monitoring the market for products that made fraudulent prevention and treatment claims. To help brands navigate, the American Herbal Products Association (AHPA) covered the topic in-depth at its 2021 AHPA Congress on Immune Supplements: Regulatory and Research...
